Thomas Bamberger is an accomplished professional in the biopharmaceutical industry, currently serving as AVP and Head of Global Biologics Network Launch Readiness at Merck since September 2025, where responsibility includes overseeing the introduction and commercialization of new products within the biologics production network. Prior experience includes a significant tenure at Boehringer Ingelheim from May 2017 to September 2025, where Thomas managed business development and key account management, as well as held various leadership roles in product and project management for biologics. Thomas's career began at Bayer, where from July 1993 to May 2017, responsibilities spanned across API manufacturing, operations management, and production management with a focus on recombinant factor VIII products. Thomas Bamberger holds a PhD in Chemical Engineering from the Karlsruhe Institute of Technology, completed in 1993.
This person is not in the org chart
This person is not in any teams
This person is not in any offices